Comparative genomic hybridization study of primary neuroblastoma tumors

Genes Chromosomes and Cancer

Volumn 18, Issue 3, 1997, Pages 162-169

  Łastowska, Maria ^a,d   Nacheva, Elizabeth ^e   McGuckin, Angela ^a,b   Curtis, Ann ^a   Grace, Colin ^c   Pearson, Andrew ^a   Bown, Nick ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c Digital Scientific Ltd   (United Kingdom)

^d Institute of Paediatrics   (Poland)

^e University of Newcastle ^*

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ARTICLE; CHILD; CHROMOSOME 17; CHROMOSOME 1P; CHROMOSOME 2P; CHROMOSOME DELETION; CONTROLLED STUDY; DNA HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; INFANT; NEUROBLASTOMA; ONCOGENE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0030939571     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2264(199703)18:3<162::aid-gcc2>3.0.co;2-%23     Document Type: Article

References (30)

1. Arheden K (1988) Amplification of the human putative oncogene INT1 in primary retinoblastoma tumors. Cytogenet Cell Genet 48:174-177.
2. Brodeur GM, Fong CH (1989) Molecular biology and genetics of human neurohlastoma. Cancer Genet Cytogenet 41:153-174.
3. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124.
4. Caron H (1995) Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 24:215-221.
5. Christiansen H, Lampert F (1988) Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 57:121-126.
6. Corvi R, Savelyeva L, Breit S, Wenzel A, Handgretinger R, Barak J, Oren M, Amler L, Schwab M (1995) Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. Oncogene 10:1081-1086.
7. Fong Ch, White PS, Peterson K, Sapienza C, Cavanee WK, Kern SE, Yogelstein B, Cantor AB, Look AT, Brodeur GM (1992) Loss of heterozygosity for chromosomes 1 and 14 defines subsets of advanced neuroblastomas. Cancer Res 52:1780-1785.
8. Gilbert F, Feder M, Balaban G, Brangman D, Lurie DK, Podolsky R, Rinaldt V, Yinikoor N, Weisband J (1984) Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 44:5444-5449.
9. Hayashi Y, Kanda N, Inaba T, Hanada R, Nagahara N, Muchi H, Yamamoto K (1988) Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63:126-132.
10. ISCN (1995) An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1995.
11. Kallioniemi A, Kallioniemi OP, Sudar D, Rudovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours. Science 258:818-821.
12. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman F, Gray JW, Pinkel D (1994a) Optimizing comparative genormt hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10:231-243.
13. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Dray JW, Waldman FM (1994b) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160.
14. Khatih ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT (1943) Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas, Cancer Res 53:5535-5541.
15. Laureys G, Speleman F, Opdenakker G, Benoit Y, Leroy J (1990) Constitutional translocation t(1:17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromosom Cancer 2:252-254.
16. Look AT, Hayes FA, Shuster JJ, Douglass EC, Castelberry RP, Bowman LC, Smith EI, Brodeur GM (1990) Clinical relevance of tumour cell ploidy and N-myc gene amplification in childhood neuroblastoma. J Clin Oncol 9:581-591.
17. Manohar CF, Salven HR, Brodeur GM, Cohn SL (1995) Coamplification and concomitant high levels of expression of DEAD box gene with MYCN in human neuroblastoma. Genes Chromosom Cancer 14:196-203.
18. Muleris M, Almeida A, Gerbault-Seureau M, Matloy B, Dutrillaux B (1994) Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosom Cancer 10:160-170.
19. Nacheva E, Grace C, Holloway TL, Green AR (1995) Comparative genomic hybridization in acute myeloid leukaemia; comparison with G-banding and chromosome painting. Cancer Genet Cytogenet 82:9-16.
20. Oppendahl BR, Storm-Mathisen I, Lie SO, Brandtzaeg P (1988) Prognostic factors in neuroblastoma: Clinical, histopathologic, immunocytochemical features and DNA ploidy in relation to prognosis. Cancer 62:778-780.
21. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PM, Collins VP (1994) Amplification of multiple genes from chromosome region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement or CDK4, SAS and MDM2. Cancer Res 54:4299-4303.
22. Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schrock E, du Manoir S, Cremer T (1994) Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 54:1801-1806.
23. Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM, Magdelanat H, Thomas G, Delattre O (1994) Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosom Cancer 10:275-281.
24. Shiloh Y, Shipley J, Brodeur G, Bruns G, Korf B, Donlon T, Schreck R, Seeger R, Sakai K, Latt S (1985) Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and medulloblastoma cell lines. Proc Natl Acad Sci USA 82:3761-3765.
25. Srivatsan ES, Ying KL, Seeger RC (1993) Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chromosom Cancer 7:32-37.
26. Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y, Kaneko Y (1994) There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosom Cancer 10:30-39.
27. Takida J, Yasuhide H, Takashi K, Masayuki S, Naohito Y, Ryoji H, Keiko Y, Jun Y (1995) Allelotype of neuroblastoma. Oncogene 11:1829-1834.
28. Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, Higabi K, Kuroiwa A, Nakagawara A, Nagahara N, Shimizu K (1987) Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer 60:820-826.
29. Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F (1994) 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosom Cancer 10:103-114.
30. Van Roy N, Forus A, Myklebost O, Ching Cheng N, Versteeg R, Speleman F (1995) Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP. Cancer Genet Cytogenet 82:151-154.